These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20864316)

  • 41. Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjögren's syndrome-associated autoimmune sialadenitis.
    Wang Y; Shnyra A; Africa C; Warholic C; McArthur C
    Arch Oral Biol; 2009 Nov; 54(11):986-96. PubMed ID: 19716548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
    Kim N; Shin Y; Choi S; Namkoong E; Kim M; Lee J; Song Y; Park K
    J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunopathology of Sjögren's syndrome.
    Tapinos NI; Polihronis M; Tzioufas AG; Skopouli FN
    Ann Med Interne (Paris); 1998 Feb; 149(1):17-24. PubMed ID: 11490512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y; Arakaki R; Ishimaru N
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apoptosis and Sjögren syndrome.
    Manganelli P; Fietta P
    Semin Arthritis Rheum; 2003 Aug; 33(1):49-65. PubMed ID: 12920696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Establishment of Sjögren's syndrome models by immunization with alpha-Fodrin: experiment with mice].
    He J; Wang H; Zhao JX; Li ZG
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2360-3. PubMed ID: 19087701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
    Hayashi Y; Haneji N; Hamano H; Yanagi K; Takahashi M; Ishimaru N
    Cell Immunol; 1996 Aug; 171(2):217-25. PubMed ID: 8806790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex differences in a murine model of Sjögren's syndrome.
    Ciháková D; Talor MV; Barin JG; Baldeviano GC; Fairweather D; Rose NR; Burek CL
    Ann N Y Acad Sci; 2009 Sep; 1173():378-83. PubMed ID: 19758176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
    Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
    J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A role for lymphotoxin in primary Sjogren's disease.
    Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
    J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Younger patients with primary Sjögren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.
    Jayakanthan K; Ramya J; Mandal SK; Sandhya P; Gowri M; Danda D
    Clin Rheumatol; 2016 Mar; 35(3):657-62. PubMed ID: 26809799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
    Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
    Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
    Hayashi Y; Ishimaru N; Arakaki R; Tsukumo S; Fukui H; Kishihara K; Shiota H; Yasutomo K; Hayashi Y
    Arthritis Rheum; 2004 Sep; 50(9):2903-10. PubMed ID: 15457459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
    Fox RI; Kang HI; Ando D; Abrams J; Pisa E
    J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N; Hamano H; Yanagi K; Hayashi Y
    J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sialoadenitis in experimental graft-versus-host disease. An animal model of Sjögren's syndrome.
    Fujiwara K; Sakaguchi N; Watanabe T
    Lab Invest; 1991 Dec; 65(6):710-8. PubMed ID: 1753714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. M3 muscarinic acetylcholine receptor reactive IL-17 producing T cells promotes development of Sjögren's syndrome like sialadenitis.
    Iizuka M; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Mod Rheumatol; 2015 Jan; 25(1):158-60. PubMed ID: 24593169
    [No Abstract]   [Full Text] [Related]  

  • 59. Labial salivary gland immunopathology in Sjögren's syndrome.
    Dalavanga YA; Drosos AA; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():67-70. PubMed ID: 3473652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.
    Li J; Ha YM; Kü NY; Choi SY; Lee SJ; Oh SB; Kim JS; Lee JH; Lee EB; Song YW; Park K
    Lab Invest; 2004 Nov; 84(11):1430-8. PubMed ID: 15448705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.